---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-012414"
form_type: "8-K"
ticker: "PRPH"
cik: "0000868278"
company_name: "ProPhase Labs, Inc."
filed_at: "2025-08-28T23:59:59+00:00"
generated_at: "2026-05-17T09:35:39.467078+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ProPhase Labs terminates $7.7M equity line with Keystone Capital Partners

## Summary
- Terminated Common Stock Purchase Agreement with Keystone Capital Partners effective August 28, 2025.
- Agreement allowed sale of up to ~$7.7M of common stock at Company’s option.
- Termination was at sole discretion, with no penalties or termination fees.
- No other material relationships between Company and Keystone.

## SEC filing metadata
- accession: 0001493152-25-012414
- form_type: 8-K
- ticker: PRPH
- cik: 0000868278
- company_name: ProPhase Labs, Inc.
- filed_at: 2025-08-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/868278/000149315225012414/0001493152-25-012414-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/868278/000149315225012414/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-012414
- JSON: https://secwatch.observer/filing/0001493152-25-012414.json
- Plain text: https://secwatch.observer/filing/0001493152-25-012414.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.